Word

LAZTREVLA

Status

Dead

Status Code

606

Status Date

Monday, January 6, 2020

Serial Number

88175882

Mark Type

4000

Filing Date

Wednesday, October 31, 2018

Published for Opposition

Tuesday, April 9, 2019

Abandoned Date

Monday, January 6, 2020

Trademark Owner History

Revance Therapeutics, Inc - Owner At Publication

Classifications

5 Pharmaceutical preparations for the treatment of neurological disorders, muscle dystonias, smooth muscle disorders, autonomic nerve disorders, headaches, wrinkles, hyperhydrosis, sports injuries, namely, injured or torn skin, muscle, ligaments, or bone, cerebral palsy, muscle spasms, muscle tremors and pain; pharmaceutical preparations, namely, peptide substrates for use in the treatment of neurological disorders, muscle dystonias, smooth muscle disorders, autonomic nerve disorders, headaches, sports injuries, namely, injured or torn skin, muscle, ligaments, or bone, cerebral palsy, muscle spasms, muscle tremors and pain; body creams, lotions and gels for medical purposes; eye creams, lotions and gels for medical purposes

Trademark Events

Jan 6, 2020

Abandonment Notice E-Mailed - No Use Statement Filed

Jan 6, 2020

Abandonment - No Use Statement Filed

Jun 4, 2019

Noa E-Mailed - Sou Required From Applicant

Apr 9, 2019

Official Gazette Publication Confirmation E-Mailed

Apr 9, 2019

Published For Opposition

Mar 20, 2019

Notification Of Notice Of Publication E-Mailed

Feb 25, 2019

Assigned To Lie

Feb 7, 2019

Approved For Pub - Principal Register

Feb 7, 2019

Examiner's Amendment Entered

Feb 7, 2019

Notification Of Examiners Amendment E-Mailed

Feb 7, 2019

Examiners Amendment E-Mailed

Feb 7, 2019

Examiners Amendment -Written

Feb 5, 2019

Assigned To Examiner

Nov 15, 2018

New Application Office Supplied Data Entered In Tram

Nov 3, 2018

New Application Entered In Tram